(Q38943177)

7 September 2017

title

Immunogenicity and antigenicity of Plasmodium vivax merozoite surface protein 10. (English)

1 reference

7 September 2017

0 references

Jetsumon Sattabongkot

3

object named as

Jetsumon Sattabongkot

1 reference

7 September 2017

Takafumi Tsuboi

5

0 references

author name string

Yang Cheng

1

1 reference

7 September 2017

Bo Wang

2

1 reference

7 September 2017

Chae Seung Lim

4

1 reference

7 September 2017

Eun-Taek Han

6

1 reference

7 September 2017

publication date

25 April 2014

1 reference

7 September 2017

published in

Parasitology Research

1 reference

7 September 2017

volume

113

1 reference

7 September 2017

issue

7

1 reference

7 September 2017

page(s)

2559-2568

1 reference

Protective immune responses elicited by immunization with a chimeric blood-stage malaria vaccine persist but are not boosted by Plasmodium yoelii challenge infection

7 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS00436-014-3907-8

The pathophysiology of vivax malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-014-3907-8

Discovery of GAMA, a Plasmodium falciparum merozoite micronemal protein, as a novel blood-stage vaccine candidate antigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-014-3907-8

High immunoglobulin G2 (IgG2) and low IgG4 levels are associated with human resistance to Plasmodium falciparum malaria

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-014-3907-8

Pre-clinical assessment of novel multivalent MSP3 malaria vaccine constructs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-014-3907-8

IL-2 contributes to maintaining a balance between CD4+Foxp3+ regulatory T cells and effector CD4+ T cells required for immune control of blood-stage malaria infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-014-3907-8

Apical location of a novel EGF-like domain-containing protein of Plasmodium falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-014-3907-8

Anti-merozoite surface protein-1 19-kDa IgG in mother-infant pairs naturally exposed to Plasmodium falciparum: subclass analysis with age, exposure to asexual parasitemia, and protection against malaria. V. The Asembo Bay Cohort Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-014-3907-8

Immunoproteomics profiling of blood stage Plasmodium vivax infection by high-throughput screening assays

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-014-3907-8

Characterization of a novel merozoite surface protein of Plasmodium vivax, Pv41.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-014-3907-8

The Plasmodium vivax merozoite surface protein 1 paralog is a novel erythrocyte-binding ligand of P. vivax

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-014-3907-8

Toward the rational design of a malaria vaccine construct using the MSP3 family as an example: contribution of immunogenicity studies in models

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-014-3907-8

Toward the rational design of a malaria vaccine construct using the MSP3 family as an example: contribution of antigenicity studies in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-014-3907-8

Regulatory T cells in malaria--friend or foe?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-014-3907-8

Plasmodium vivax and mixed infections are associated with severe malaria in children: a prospective cohort study from Papua New Guinea

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-014-3907-8

Vaccination with recombinant Plasmodium vivax MSP-10 formulated in different adjuvants induces strong immunogenicity but no protection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-014-3907-8

An update on the search for a Plasmodium vivax vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-014-3907-8

Low plasma concentrations of interleukin-10 in severe malarial anaemia compared with cerebral and uncomplicated malaria.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-014-3907-8

Immunity to malaria: more questions than answers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-014-3907-8

Naturally acquired humoral and cellular immune responses to Plasmodium vivax merozoite surface protein 9 in Northwestern Amazon individuals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-014-3907-8

A reduced risk of infection with Plasmodium vivax and clinical protection against malaria are associated with antibodies against the N terminus but not the C terminus of merozoite surface protein 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-014-3907-8

Evidence of purifying selection on merozoite surface protein 8 (MSP8) and 10 (MSP10) in Plasmodium spp.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-014-3907-8

Identifying and characterising the Plasmodium falciparum merozoite surface protein 10 Plasmodium vivax homologue.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-014-3907-8

Heroes or villains? T regulatory cells in malaria infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-014-3907-8

Protection against malaria by MSP3 candidate vaccine

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-014-3907-8

Interleukin-2: inception, impact, and implications

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-014-3907-8

Multidrug-resistant Plasmodium vivax associated with severe and fatal malaria: a prospective study in Papua, Indonesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-014-3907-8

Wheat germ cell-free system-based production of malaria proteins for discovery of novel vaccine candidates

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-014-3907-8

An efficient approach to the production of vaccines against the malaria parasite

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-014-3907-8

Merozoite surface protein-9 of Plasmodium vivax and related simian malaria parasites is orthologous to p101/ABRA of P. falciparum

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00436-014-3907-8

Testing the efficacy of a recombinant merozoite surface protein (MSP-1(19) of Plasmodium vivax in Saimiri boliviensis monkeys

21 January 2018

1 reference

12 December 2020

Recombinant tumour necrosis factor inhibits malaria parasites in vivo but not in vitro.

1 reference

12 December 2020

Antigenicity, immunogenicity, and protective efficacy of Plasmodium vivax MSP1 PV200l: a potential malaria vaccine subunit

1 reference

12 December 2020

Merozoite surface protein-3: a malaria protein inducing antibodies that promote Plasmodium falciparum killing by cooperation with blood monocytes

1 reference

12 December 2020

Analysis of naturally acquired antibody responses to the 19-kd C-terminal region of merozoite surface protein-1 of Plasmodium vivax from individuals in Sanliurfa, Turkey.

1 reference

12 December 2020

Antimalarial antibodies of the immunoglobulin G2a isotype modulate parasitemias in mice infected with Plasmodium yoelii

1 reference

12 December 2020

Cytokines in the pathogenesis of and protection against malaria

1 reference

12 December 2020

Acquired immune responses to the N- and C-terminal regions of Plasmodium vivax merozoite surface protein 1 in individuals exposed to malaria

1 reference

12 December 2020

10.1007/S00436-014-3907-8

Identifiers

DOI

1 reference

Dimensions Publication ID

7 September 2017

1011499376

0 references

1 reference